Male Hypogonadism Market - Global Industry Analysis

Male Hypogonadism Market- by Therapy (Testosterone replacement therapy, Gonadotropin-releasing hormones therapy), by Drug delivery (Injectables, Topical gels, Transdermal patches, Others), by Type (Kallmann syndrome, Klinefelters syndrome, Pituitary disorders, Others) - Global Industry Perspective Comprehensive Analysis and Forecast, 2020 - 2026

Published Date: 30-Nov-2020 Category: Biotechnology Report Format : PDF Pages: 110 Report Code: ZMR-1527 Status : Published

According to the report, global demand for Male Hypogonadism market was valued at approximately USD 3467.7 million in 2019, and is expected to generate revenue of around USD 4323.2 million by end of 2026, growing at a CAGR of around 3.2 % between 2020 and 2026.

Description

According to the report, global demand for Male Hypogonadism market was valued at approximately USD 3467.7 million in 2019, and is expected to generate revenue of around USD 4323.2 million by end of 2026, growing at a CAGR of around 3.2 % between 2020 and 2026.

Global Male Hypogonadism Market: Overview

Male hypogonadism is a medical condition, wherein the testes fail to generate enough testosterone which leads to incomplete development or delayed puberty. The condition is related to the development of breast tissues, impaired development of muscle mass, lack of deepening of the voice, and impaired body hair growth.

Global Male Hypogonadism Market: Segmentation

The male hypogonadism market is globally segmented into therapy, drug delivery, and type. On the basis of therapy, the market is segregated into testosterone replacement therapy and gonadotropin-releasing hormones therapy. The gonadotropin-releasing hormones therapy is further sub-divided into luteinizing hormone (LH), human chorionic gonadotropin (hCG), follicle-stimulating hormone (FSH), and gonadotropin-releasing hormone (GnRH). Based on the drug delivery, the market is categorized into injectables, topical gels, transdermal patches, and others. Depending on the type, the market is divided into Kallmann syndrome, Klinefelters syndrome, pituitary disorders, and others.

Global Male Hypogonadism Market: Growth Factors

The key factor that is driving the male hypogonadism market includes increasing cases of testosterone deficiency among men, increasing awareness among people about hypogonadism treatment owing to awareness drives that are organized by several governments across the world, and increasing infertility rates. The high risk of hypogonadism among the aged population with obesity and diabetes and escalating cases of chronic disorders among the geriatrics are further boosting the market’s growth. On the other hand, factors such as high side effects of testosterone products challenge the growth of the market. The market players are focusing on research and development activities to introduce newer products with less or negligible side effects and better results. Technological advancements are anticipated to extend new opportunities to the market’s growth.

Global Male Hypogonadism Market: Regional Analysis

The male hypogonadism market can be segmented into regions such as North America, Asia-Pacific, Europe, Latin America, and the Middle East and Africa. North America dominates the market owing to the increase in the number of individuals that are suffering from the primary and secondary conditions of hypogonadism, and the rising awareness among the people about treatment. Other factors that contribute to this growth are the presence of unconventional health care infrastructure and growing popularity of the technologically advanced products which will offer new opportunities to the top market players in this market. The region is strongly followed by Europe. Asia-Pacific region is expected to offer productive opportunities to this market owing to the modernization of the healthcare infrastructure in the developing economies of India and China and the growing awareness about the treatment for the condition. In Asia Pacific, there is a rise in the number of people that suffer from hypogonadism and infertility rates coupled with the rise in the geriatric population base having obesity and diabetes are triggering the growth of the market.

Global Male Hypogonadism Market: Competitive Players

Some of the key market players that are involved in the male hypogonadism market include Astrazeneca Plc., Merck & Co. Inc., Laboratories Genevrier, Allergan Plc., Endo International Plc., Ferring, AbbVie Inc., Eli Lilly and Company Ltd., Finox Biotech, Teva Pharmaceutical Industries Ltd., Bayer AG, and IBSA Institut Biochimque.

The report segments the Global Male Hypogonadism market as follows:

Global Male Hypogonadism Market: Therapy Segment Analysis

  • Testosterone replacement therapy
  • Gonadotropin-releasing hormones therapy
    • Luteinizing Hormone (LH)
    • Human Chorionic Gonadotropin (hcg)
    • Follicle-Stimulating Hormone (FSH)
    • Gonadotropin-Releasing Hormone (GnRH)

Global Male Hypogonadism Market: Drug delivery Segment Analysis

  • Injectables
  • Topical gels
  • Transdermal patches
  • Others

Global Male Hypogonadism Market: Type Segment Analysis

  • Kallmann syndrome
  • Klinefelters syndrome
  • Pituitary disorders
  • Others

Global Male Hypogonadism Market: Regional Segment Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Pituitary disorders Scope
    • 1.3. Pituitary disorders Methodology
      • 1.3.1. Market Pituitary disorders Process
      • 1.3.2. Market Pituitary disorders Methodology
  • Chapter 2. Executive Summary
    • 2.1. Male Hypogonadism Market, 2016 - 2026, (USD Million)
    • 2.2. Male Hypogonadism Market: Snapshot
  • Chapter 3. Global Male Hypogonadism Market – Industry Analysis
    • 3.1. Male Hypogonadism Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Increasing case of testosterone deficiency among men.
      • 3.2.2. Rising infertility rates accompanied with rising awareness among individuals regarding hypogonadism treatment
    • 3.3. Restraints
      • 3.3.1. High side effects
    • 3.4. Opportunity
      • 3.4.1. Increase in research and development in pharmaceutical sector
    • 3.5. Porter’s Five Forces Analysis
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis by Therapy segment
      • 3.6.2. Market attractiveness analysis by Drug delivery segment
      • 3.6.3. Market attractiveness analysis by Type segment
      • 3.6.4. Market attractiveness analysis by regional segment
  • Chapter 4. Global Male Hypogonadism Market - Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Male Hypogonadism market: company market share analysis, 2018
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Disease category launches
      • 4.2.3. Agreements, partnerships, cullaborations and joint ventures
      • 4.2.4. Pituitary disorders and development and regional expansion
  • Chapter 5. Global Male Hypogonadism Market – Therapy Segment Analysis
    • 5.1. Global Male Hypogonadism market overview: by Therapy
      • 5.1.1. Global Male Hypogonadism market revenue share, by Therapy, 2019 and 2026
    • 5.2. Testosterone replacement therapy
      • 5.2.1. Global Male Hypogonadism market by Testosterone replacement therapy, 2016-2026 (USD Million)
    • 5.3. Gonadotropin-releasing hormones therapy
      • 5.3.1. Global Male Hypogonadism market by Gonadotropin-releasing hormones therapy, 2016-2026 (USD Million)
  • Chapter 6. Global Male Hypogonadism Market – Drug delivery Segment Analysis
    • 6.1. Global Male Hypogonadism market overview: by Drug delivery
      • 6.1.1. Global Male Hypogonadism market revenue share, by Drug delivery, 2019 and 2026
    • 6.2. Injectables
      • 6.2.1. Global Male Hypogonadism market by Injectables, 2016-2026 (USD Million)
    • 6.3. Topical gels
      • 6.3.1. Global Male Hypogonadism market by Topical gels, 2016-2026 (USD Million)
    • 6.4. Transdermal patches
      • 6.4.1. Global Male Hypogonadism market by Transdermal patches, 2016-2026 (USD Million)
    • 6.5. Others
      • 6.5.1. Global Male Hypogonadism market by Others, 2016-2026 (USD Million)
  • Chapter 7. Global Male Hypogonadism Market – Type Segment Analysis
    • 7.1. Global Male Hypogonadism market overview: by Type
      • 7.1.1. Global Male Hypogonadism market revenue share, by Type, 2019 and 2026
    • 7.2. Kallmann syndrome
      • 7.2.1. Global Male Hypogonadism market by Kallmann syndrome, 2016-2026 (USD Million)
    • 7.3. Klinefelters syndrome
      • 7.3.1. Global Male Hypogonadism market by Klinefelters syndrome, 2016-2026 (USD Million)
    • 7.4. Pituitary disorders
      • 7.4.1. Global Male Hypogonadism market by Pituitary disorders, 2016-2026 (USD Million)
    • 7.5. Transplant
      • 7.5.1. Global Male Hypogonadism market by Transplant, 2016-2026 (USD Million)
  • Chapter 8. Global Male Hypogonadism Market - Regional Analysis
    • 8.1. Global Male Hypogonadism market overview: by region
      • 8.1.1. Global Male Hypogonadism market revenue share, by region, 2019 and 2026
    • 8.2. North America
      • 8.2.1. North America Male Hypogonadism market, by country, 2016-2026 (USD Million)
      • 8.2.2. North America Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
      • 8.2.3. North America Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
      • 8.2.4. North America Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)
      • 8.2.5. The U.S.
        • 8.2.5.1. The U.S. Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
        • 8.2.5.2. The U.S. Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
        • 8.2.5.3. The U.S. Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)
      • 8.2.6. Rest of North America
        • 8.2.6.1. Rest of North America Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
        • 8.2.6.2. Rest of North America Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
        • 8.2.6.3. Rest of North America Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)
    • 8.3. Europe
      • 8.3.1. Europe Male Hypogonadism market, by country, 2016-2026 (USD Million)
      • 8.3.2. Europe Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
      • 8.3.3. Europe Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
      • 8.3.4. Europe Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)
      • 8.3.5. U.K.
        • 8.3.5.1. U.K. Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
        • 8.3.5.2. U.K. Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
        • 8.3.5.3. U.K. Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)
      • 8.3.6. France
        • 8.3.6.1. France Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
        • 8.3.6.2. France Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
        • 8.3.6.3. France Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)
      • 8.3.7. Germany
        • 8.3.7.1. Germany Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
        • 8.3.7.2. Germany Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
        • 8.3.7.3. Germany Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)
      • 8.3.8. Rest of Europe
        • 8.3.8.1. Rest of Europe Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
        • 8.3.8.2. Rest of Europe Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
        • 8.3.8.3. Rest of Europe Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific Male Hypogonadism market, by country, 2016-2026 (USD Million)
      • 8.4.2. Asia Pacific Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
      • 8.4.3. Asia Pacific Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
      • 8.4.4. Asia Pacific Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)
      • 8.4.5. China
        • 8.4.5.1. China Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
        • 8.4.5.2. China Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
        • 8.4.5.3. China Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)
      • 8.4.6. Japan
        • 8.4.6.1. Japan Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
        • 8.4.6.2. Japan Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
        • 8.4.6.3. Japan Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)
      • 8.4.7. India
        • 8.4.7.1. India Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
        • 8.4.7.2. India Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
        • 8.4.7.3. India Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)
      • 8.4.8. Rest of Asia Pacific
        • 8.4.8.1. Rest of Asia Pacific Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
        • 8.4.8.2. Rest of Asia Pacific Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
        • 8.4.8.3. Rest of Asia Pacific Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)
    • 8.5. Latin America
      • 8.5.1. Latin America Male Hypogonadism market, by country, 2016-2026 (USD Million)
      • 8.5.2. Latin America Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
      • 8.5.3. Latin America Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
      • 8.5.4. Latin America Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)
      • 8.5.5. Brazil
        • 8.5.5.1. Brazil Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
        • 8.5.5.2. Brazil Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
        • 8.5.5.3. Brazil Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)
      • 8.5.6. Rest of Latin America
        • 8.5.6.1. Rest of Latin America Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
        • 8.5.6.2. Rest of Latin America Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
        • 8.5.6.3. Rest of Latin America Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)
    • 8.6. Middle East & Africa
      • 8.6.1. Middle East & Africa Male Hypogonadism market, 2016-2026 (USD Million)
      • 8.6.2. Middle East & Africa Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
      • 8.6.3. Middle East & Africa Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
      • 8.6.4. Middle East & Africa Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)
  • Chapter 9. Company Profiles
    • 9.1. Astrazeneca Plc
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Product Portfolio
      • 9.1.4. Business Strategy
      • 9.1.5. Recent Developments
    • 9.2. Merck & Co. Inc.
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Product Portfolio
      • 9.2.4. Business Strategy
      • 9.2.5. Recent Developments
    • 9.3. Laboratories Genevrier
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Product Portfolio
      • 9.3.4. Business Strategy
      • 9.3.5. Recent Developments
    • 9.4. Allergan Plc.
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Product Portfolio
      • 9.4.4. Business Strategy
      • 9.4.5. Recent Developments
    • 9.5. Endo International Plc
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Product Portfolio
      • 9.5.4. Business Strategy
      • 9.5.5. Recent Developments
    • 9.6. Ferring.
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Product Portfolio
      • 9.6.4. Business Strategy
      • 9.6.5. Recent Developments
    • 9.7. AbbVie Inc
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Product Portfolio
      • 9.7.4. Business Strategy
      • 9.7.5. Recent Developments
    • 9.8. Eli Lilly and Company Ltd
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Product Portfolio
      • 9.8.4. Business Strategy
      • 9.8.5. Recent Developments
    • 9.9. Finox Biotech.
      • 9.9.1. Overview
      • 9.9.2. Financials
      • 9.9.3. Product Portfolio
      • 9.9.4. Business Strategy
      • 9.9.5. Recent Developments
    • 9.10. Teva Pharmaceutical Industries Ltd
      • 9.10.1. Overview
      • 9.10.2. Financials
      • 9.10.3. Product Portfolio
      • 9.10.4. Business Strategy
      • 9.10.5. Recent Developments

Table Of Figures

List of Figures

1. Market Pituitary disorders process
2. Market Pituitary disorders methodology
3. Global Male Hypogonadism market, 2016-2026 (USD Million)
4. Porter’s five forces analysis: Male Hypogonadism market
5. Global Male Hypogonadism market attractiveness, by Therapy
6. Global Male Hypogonadism market attractiveness, by Drug delivery
7. Global Male Hypogonadism market attractiveness, by Type
8. Global Male Hypogonadism market revenue share, by Therapy, 2019 and 2026
9. Global Male Hypogonadism market by Testosterone replacement therapy, 2016-2026 (USD Million)
10. Global Male Hypogonadism market by Gonadotropin-releasing hormones therapy, 2016-2026 (USD Million)
11. Global Male Hypogonadism market revenue share, by Drug delivery, 2019 and 2026
12. Global Male Hypogonadism market by Injectables, 2016-2026 (USD Million)
13. Global Male Hypogonadism market by Topical gels, 2016-2026 (USD Million)
14. Global Male Hypogonadism market by Transdermal patches, 2016-2026 (USD Million)
15. Global Male Hypogonadism market by Others, 2016-2026 (USD Million)
16. Global Male Hypogonadism market revenue share, by Type, 2019 and 2026
17. Global Male Hypogonadism market by Kallmann syndrome, 2016-2026 (USD Million)
18. Global Male Hypogonadism market by Klinefelters syndrome, 2016-2026 (USD Million)
19. Global Male Hypogonadism market by Pituitary disorders, 2016-2026 (USD Million)
20. Global Male Hypogonadism market by Others, 2016-2026 (USD Million)
21. Global Male Hypogonadism market revenue share, by region, 2018 & 2025
22. North America Male Hypogonadism market, 2016-2026 (USD Million)
23. Europe Male Hypogonadism market, 2016-2026 (USD Million)
24. Asia Pacific Male Hypogonadism market, 2016-2026 (USD Million)
25. Latin America Male Hypogonadism market, 2016-2026 (USD Million)
26. Middle East & Africa Male Hypogonadism market, 2016-2026 (USD Million)
 


Table Of Tables

List of Tables

1. Global Male Hypogonadism market: snapshot
2. Drivers for Male Hypogonadism market: impact analysis
3. Restraints for Male Hypogonadism market: impact analysis
4. North America Male Hypogonadism market revenue, by country, 2016-2026 (USD Million)
5. North America Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
6. North America Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
7. North America Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)
8. The U.S. Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
9. The U.S. Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
10. The U.S. Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)
11. Rest of North America Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
12. Rest of North America Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
13. Rest of North America Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)
14. Europe Male Hypogonadism market revenue, by country, 2016-2026 (USD Million)
15. Europe Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
16. Europe Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
17. Europe Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)
18. U.K. Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
19. U.K. Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
20. U.K. Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)
21. France Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
22. France Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
23. France Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)
24. Germany Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
25. Germany Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
26. Germany Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)
27. Rest of Europe Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
28. Rest of Europe Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
29. Rest of Europe Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)
30. Asia Pacific Male Hypogonadism market revenue, by country, 2016-2026 (USD Million)
31. Asia Pacific Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
32. Asia Pacific Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
33. Asia Pacific Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)
34. China Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
35. China Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
36. China Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)
37. Japan Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
38. Japan Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
39. Japan Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)
40. India Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
41. India Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
42. India Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)
43. Rest of Asia Pacific Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
44. Rest of Asia Pacific Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
45. Rest of Asia Pacific Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)
46. Latin America Male Hypogonadism market revenue, by country, 2016-2026 (USD Million)
47. Latin America Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
48. Latin America Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
49. Latin America Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)
50. Brazil Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
51. Brazil Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
52. Brazil Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)
53. Rest of Latin America Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
54. Rest of Latin America Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
55. Rest of Latin America Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)
56. Middle East & Africa Male Hypogonadism market revenue, by Therapy, 2016-2026 (USD Million)
57. Middle East & Africa Male Hypogonadism market revenue, by Drug delivery, 2016-2026 (USD Million)
58. Middle East & Africa Male Hypogonadism market revenue, by Type, 2016-2026 (USD Million)

Methodology

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • paypal
  • amazon
  • visa
  • master card

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed